We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Vols saber com serà la teva estada a l’Hospital Universitari Vall d’Hebron? Aquí trobaràs tota la informació.
Dr. Robert Medcalf, NHMRC Principal Research Fellow and Director of the Molecular Neurotrauma and Haemostasis Group, Monash, Melbourne
"Plasminogen activation and stroke: can we predict thrombolysis outcome?"
Robert Medcalf was awarded his Ph.D. from the University of Melbourne in 1984. His first post-doctoral appointment was at the University of Melbourne where he investigated the role of the plasminogen activating system in rheumatoid arthritis. In 1986, he continued his research in Lausanne, Switzerland where he extended his interest in the field of plasminogen activation and fibrinolysis. In 1993, he returned to Australia where he established a laboratory at Monash University in Melbourne. He was appointed as a NHMRC Senior Research Fellow in 2003. He has published more than 90 papers in peer reviewed journals on fibrinolysis and plasminogen activation and has an H-index of 30. Since 2000, his research has attracted more than $7m in peer reviewed funding from the NHMRC, the National Heart Foundation, the Brain Research Foundation and the Victorian Neurotrauma Initiative. He was elected as Chairman of the International Society on Fibrinolysis and Proteolysis (ISFP) in 2004 and in 2008 and he will also be Congress President of the 2019 meeting of the International Society on Thrombosis and Haemostasis (ISTH) in Melbourne. He is Associate Editor of the Journal of Thrombosis and Haemostasis which is the flagship journal of both the ISFP and the ISTH and is on the Editorial Board of the Journal of Biological Chemistry.
Host: Neurovascular Research Group (VHIR) alejandro.bustamante@vhir.org
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.